US Patent 11753369 Creatine prodrugs, compositions and methods of use thereof
Patent 11753369 was granted and assigned to Ultragenyx Pharmaceutical on September, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+26 properties)
Article (+130 characters)
US Patent 11753369 Creatine prodrugs, compositions and methods of use thereof
Article
The present disclosure provides creatine prodrug analogs and their compositions useful for the treatment of creatine deficiencies.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11753369
Patent Inventor Names
Alexandra Trotier-Faurion
Arjun Natesan
David Lapointe
Emil D. Kakkis
Mike E. Lizarzaburu
Paul Lee
Sharyl Fyffe-Maricich
William F. Brubaker
Yiumo Chan
Date of Patent
September 12, 2023
Patent Application Number
17706283
Date Filed
March 28, 2022
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11753369 Creatine prodrugs, compositions and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
